$16.99
0.00 (0%)
Phase Forward, Inc. (NASDAQ:PFWD)
CAPS Rating:
A provider of integrated enterprise-level software products, services and hosted solutions for use in its customers' global clinical trial and drug safety monitoring activities.
RSS Headlines
Fool UK